COPD patients’ body composition and its impact on lung function

##plugins.themes.academic_pro.article.main##

Meriem Mjid
Houda Snène
Abir Hedhli
Sana Cheikh Rouhou
Sonia Toujani
Besma Dhahri

Abstract

Introduction: Despite fat-free mass index (FFMI) is one of the strongest predictive factors of survival during chronic obstructive pulmonary disease (COPD), there is a considerable lack of information regarding body composition in Tunisian patients with COPD.  
Aim: Describe the body composition of Tunisian patients followed for COPD and examine the relationship between body composition and the severity of the disease.
Methods: Cross-sectional study of patients with stable COPD. Body composition was assessed by bioelectrical impedance analysis. Pulmonary function tests (PFT) included spirometry with plethysmography and the six-minute walking test. The severity of dyspnea was assessed by the mMRC scale.
Results: During the study period, 104 patients with stable COPD were included (average age= 65.9 years and average FEV1= 49.3%). Fifty-four percent of patients were GOLD D stage. According to the IMM, malnutrition was identified in 20.2% of cases. Patients with low FFMI were the most symptomatic, had a more severe air flow limitation and a more severe disease. The walking distance was lower in malnourished patients. However, FFMI was not significantly associated with exercise capacity.
Conclusions: Malnutrition is highly prevalent in COPD patients and is correlated to the severity of the disease. Thus, body composition analysis should be considered in COPD patient management.

Keywords:

Malnutrition, Lean mass, Fat mass, Bioelectrical impedance analysis, Tunisia

##plugins.themes.academic_pro.article.details##

References

  1. References: 1. Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med 2013;1:73-83. 2. Hallin R, Gudmundsson G, Suppli Ulrik C, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med 2007;101:1954-60. 3. Gupta B, Kant S, Mishra R. Subjective global assessment of nutritional status of chronic obstructive pulmonary disease patients on admission. Int J Tuberc Lung Dis 2010;14:500-5. 4. Collins PF, Elia M, Stratton RJ. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology 2013;18:616-29. 5. Chambaneau A, Filaire M, Jubert L, Bremond M, Filaire E. Nutritional intake, physical activity and quality of life in COPD patients. Int J Sports Med 2016;37:730-7. 6. Hoong JM, Ferguson M, Hukins C, Collins PF. Economic and operational burden associated with malnutrition in chronic obstructive pulmonary disease. Clin Nutr 2017;36:1105-9. 7. Chao C, Wang R, Wang J, Bunjhoo H, Xu Y, Xiong W. Body mass index and mortality in chronic obstructive pulmonary disease: a metaanalysis. PLoS One 2012;7:e43892. 8. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:961-6. 9. White JV, Guenter P, Jensen G, Malone A, Schofield M. Consensus Statement: Academy of Nutrition and Dietetics and American Society for parenteral and enteral nutrition. J Parenter Enter Nutr 2012;36:275-83. 10. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83. 11. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. The Am J Clin Nutr 2005;82:53-9. 12. Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 2007;132:164-9. 13. Schols AM, Ferreira IM, Franssen FM, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J 2014;44:1504-20. 14. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. Updated 2019. http://www.goldcopd.org/. [Accessed March 25,2020]. 15. Miller MR, Hankinson J, Brusasco V. Series ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 2005;26:319-38. 16. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005;26:153-61. 17. American Thoracic Society. ATS Statement: Guidelines for the Six- Minute Walk Test. Am J Respir Crit Care Med 2002;166:111-7. 18. Engelen MP, Schols AM, Heidendal GA, Wouters EF. Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1998;68:1298-303. 19. Miller A, Strauss BJ, Mol S, et al. Dual-energy X-ray absorptiometry is the method of choice to assess body composition in COPD. Respirology 2009;14:411-8. 20. Lerario MC, Sachs A, Lazaretti-Castro M, Saraiva LG, Jardim JR. Body composition in patients with chronic obstructive pulmonary disease: which method to use in clinical practice? Br J Nutr 2006;96:86-92. 21. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Br J Nutr 2006;96:86-92. 22. Vermeeren MA, Creutzberg EC, Schols AM, et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006;100:1349-55. 23. Humphreys K, Cross G, Frith P, Cafarella P. Nutritional status and dietary intake of outpatients with chronic obstructive pulmonary disease. Nutr Diet 2008;65:168-74. 24. Norden J, Grönberg AM, Bosaeus I, et al. Nutrition impact symptoms and body composition in patients with COPD. Eur J Clin Nutr 2015;69:256-61. 25. Luo Y, Zhou L, Li Y, et al. Fat-free mass index for evaluating the nutritional status and disease severity in COPD. Respir Care 2016;61:680-8. 26. Ko GT, Tang J, Chan JC, et al. Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr 2001;85:239-42. 27. Gologanu D, Ionita D, Gartonea T, Stanescu C, Bogdan MA. Body composition in patients with chronic obstructive pulmonary disease. Maedica 2014;9:25-32. 28. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, et al. Respiratory insufficiency related to COPD accelerates systemic inflammation, undernutrition, and angiogenesis in esophageal malignancies. Exp Oncol 2008;30:75-80. 29. Plataki M, Tzortzaki E, Rytila P, Demosthenes M, Koutsopoulos A, Siafakas NM. Apoptotic mechanisms in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis 2006;1:161-71. 30. Schols AMWJ. Nutrition in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2000;6:110-115. 31. Agusti AG, Sauleda J, Miralles C, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:485-59.